Hong SS - Search Results

1

Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.

Yin D, He Y, Perera MA, Hong SS, Marhefka C, Stourman N, Kirkovsky L, Miller DD, Dalton JT. Yin D, et al. Among authors: hong ss. Mol Pharmacol. 2003 Jan;63(1):211-23. doi: 10.1124/mol.63.1.211. Mol Pharmacol. 2003. PMID: 12488554

2

Preclinical pharmacology of a nonsteroidal ligand for androgen receptor-mediated imaging of prostate cancer.

Yang J, Bohl CE, Nair VA, Mustafa SM, Hong SS, Miller DD, Dalton JT. Yang J, et al. Among authors: hong ss. J Pharmacol Exp Ther. 2006 Apr;317(1):402-8. doi: 10.1124/jpet.105.094334. Epub 2006 Jan 24. J Pharmacol Exp Ther. 2006. PMID: 16434567

3

Pharmacokinetics, biodistribution and metabolism of a novel selective androgen receptor modulator designed for prostate cancer imaging.

Yang J, Wu Z, Wu D, Darby MV, Hong SS, Miller DD, Dalton JT. Yang J, et al. Among authors: hong ss. Int J Oncol. 2010 Jan;36(1):213-22. Int J Oncol. 2010. PMID: 19956850

4

Biochemical activities of trimetoquinol analogs at human beta(1)- and beta(3)-adrenergic receptors.

Konkar AA, Nikulin VI, De Los Angeles J, Hong SS, Fertel RH, Miller DD, Feller DR. Konkar AA, et al. Among authors: hong ss. Pharmacology. 2001 Jan;62(1):45-55. doi: 10.1159/000056071. Pharmacology. 2001. PMID: 11150922

5

Bioisosteric phentolamine analogs as selective human alpha(2)- versus alpha(1)-adrenoceptor ligands.

Bavadekar SA, Hong SS, Lee SI, Miller DD, Feller DR. Bavadekar SA, et al. Among authors: hong ss. Eur J Pharmacol. 2008 Aug 20;590(1-3):53-60. doi: 10.1016/j.ejphar.2008.05.027. Epub 2008 May 29. Eur J Pharmacol. 2008. PMID: 18589415

6

Medetomidine analogs as selective agonists for the human alpha2-adrenoceptors.

Lalchandani SG, Zhang X, Hong SS, Liggett SB, Li W, Moore BM 2nd, Miller DD, Feller DR. Lalchandani SG, et al. Among authors: hong ss. Biochem Pharmacol. 2004 Jan 1;67(1):87-96. doi: 10.1016/j.bcp.2003.08.043. Biochem Pharmacol. 2004. PMID: 14667931

7

Synthesis and biological evaluation of novel cytotoxic phospholipids for prostate cancer.

Gududuru V, Hurh E, Durgam GG, Hong SS, Sardar VM, Xu H, Dalton JT, Miller DD. Gududuru V, et al. Among authors: hong ss. Bioorg Med Chem Lett. 2004 Oct 4;14(19):4919-23. doi: 10.1016/j.bmcl.2004.07.026. Bioorg Med Chem Lett. 2004. PMID: 15341952

8

A structure-activity relationship study of benzylic modifications of 4-[1-(1-naphthyl)ethyl]-1H-imidazoles on alpha 1- and alpha 2-adrenergic receptors.

Hong SS, Romstedt KJ, Feller DR, Hsu FL, Cupps TL, Lyon RA, Miller DD. Hong SS, et al. J Med Chem. 1994 Jul 22;37(15):2328-33. doi: 10.1021/jm00041a011. J Med Chem. 1994. PMID: 7914537

9

Estrogen receptor beta selective nonsteroidal estrogens: seeking clinical indications.

Mohler ML, Narayanan R, Coss CC, Hu K, He Y, Wu Z, Hong SS, Hwang DJ, Miller DD, Dalton JT. Mohler ML, et al. Among authors: hong ss. Expert Opin Ther Pat. 2010 Apr;20(4):507-34. doi: 10.1517/13543771003657164. Expert Opin Ther Pat. 2010. PMID: 20302450 Review.

10

Discovery of antiglioma activity of biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues.

Mohler ML, Kang GS, Hong SS, Patil R, Kirichenko OV, Li W, Rakov IM, Geisert EE, Miller DD. Mohler ML, et al. Among authors: hong ss. J Med Chem. 2006 Sep 21;49(19):5845-8. doi: 10.1021/jm060020x. J Med Chem. 2006. PMID: 16970409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

748 results

Search Page

Filters